drugset / Trial / NCT00174980

Study of Oxycyte in Severe Closed Head Injury

NCT00174980 ↗

Phase 2 Terminated 9 enrolled Tenax Therapeutics, Inc.
NaSingle-groupOpen-labelTreatment

Summary

Brain damage as a result of decreased oxygen to the brain is found in 80% of patients that die with severe head injuries. Laboratory studies in animals and clinical trials have shown that increasing oxygen in the brain results in better brain oxygen consumption, less cell death, and better functional outcome. This study will test the hypothesis that Oxycyte is an effective way to increase brain oxygen levels in severe head injury.

Timeline

Start
2005-09
Primary completion
2008-03
Completion
2008-04

Outcome

Outcome not reported

Stopped (Enrollment): “Low enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Subject PERFLUORO TERT-BUTYLCYCLOHEXANE Other / unclassified 3 unknown Intravenous